121 related articles for article (PubMed ID: 10330987)
1. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.
Wang M; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987
[No Abstract] [Full Text] [Related]
2. Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1.Au alloantigen.
Wang M; Stepkowski SM; Yu J; Wang M; Kahan BD
Transplantation; 1997 May; 63(10):1373-9. PubMed ID: 9175796
[TBL] [Abstract][Full Text] [Related]
3. Localization of tolerogenic epitopes in the alpha 1 helical region of the rat class I major histocompatibility complex molecule.
Stepkowski SM; Wang M; Langowski J; Ghobrial R; Qu X; Yu J; Tian L; Kahan BD
Transplant Proc; 1997 May; 29(3):1663-4. PubMed ID: 9142223
[No Abstract] [Full Text] [Related]
4. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
[TBL] [Abstract][Full Text] [Related]
5. Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.
Semiletova NV; Shen XD; Feldman DM; Gao F; Mhoyan A; Liu D; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Cell Immunol; 2007 Jul; 248(1):48-58. PubMed ID: 17936255
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts.
Perez J; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1999 May; 31(3):1560. PubMed ID: 10331000
[No Abstract] [Full Text] [Related]
7. Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein.
Stepkowski SM; Yu J; Wang M; Kahan BD
Transplant Proc; 1999 May; 31(3):1557. PubMed ID: 10330998
[No Abstract] [Full Text] [Related]
8. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
[TBL] [Abstract][Full Text] [Related]
9. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
Okamoto M; Stepkowski SM; Wang M; Kahan BD
Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
[TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
12. Selection of lowly immunogenic and highly tolerogenic donor and recipient allochimeric class I major histocompatibility complex proteins.
Perez J; Stepkowski SM; Song P; Trawick B; Wang ME; Janczewska S; Kahan BD
Transplantation; 2003 Oct; 76(8):1201-7. PubMed ID: 14578754
[TBL] [Abstract][Full Text] [Related]
13. Tolerance induction by alteration of T cell receptor (TCR) signaling using an allochimeric donor/recipient class I MHC protein.
Stepkowski SM; Kirken RA; Wang M; Yu J; Akioka K; Kahan BD
Transplant Proc; 2001; 33(1-2):131. PubMed ID: 11266741
[No Abstract] [Full Text] [Related]
14. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
Graeb C; Scherer MN; Knechtle SJ; Geissler EK
Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
[TBL] [Abstract][Full Text] [Related]
15. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.
Wang M; Stepkowski SM; Wang ME; Tian L; Qu X; Tu Y; He G; Kahan BD
Transplantation; 1996 Feb; 61(3):448-57. PubMed ID: 8610360
[TBL] [Abstract][Full Text] [Related]
16. Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.
Geissler EK; Graeb C; Jauch KW; Scherer MN
Transplant Proc; 1999; 31(1-2):742-3. PubMed ID: 10083316
[No Abstract] [Full Text] [Related]
17. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
[TBL] [Abstract][Full Text] [Related]
18. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides.
Chowdhury NC; Murphy B; Sayegh MH; Jin MX; Roy DK; Hardy MA; Oluwole SF
Transplantation; 1996 Dec; 62(12):1878-82. PubMed ID: 8990380
[TBL] [Abstract][Full Text] [Related]
19. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a second class II (Ia) antigenic system in rats linked to RT1.
Carpenter CB; Terranova CM; Milford EL; Lowry RP; Vitetta E; Paradysz JM; Norman DJ; Norris S
Transplant Proc; 1979 Sep; 11(3):1582-3. PubMed ID: 159526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
